leucine has been researched along with B16 Melanoma in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (26.32) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; He, X; Hu, H; Huang, W; Li, B; Li, Y; Liu, J; Liu, W; Peng, Z; Tan, L; Yan, SM; Yu, F; Yuan, Y; Zhang, H; Zhang, Y | 1 |
| Chen, XQ; Li, L; Ma, C; Wang, RF; Yan, P; Yin, L; Zhao, Q | 1 |
| Cha, JY; Cho, YS; Moon, HI; Yang, HJ | 1 |
| Papo, N; Shai, Y | 1 |
| Koizumi, K; Minami, T; Saiki, I; Saitoh, Y; Sakurai, H; Sekine, K | 1 |
| Carmona, AK; Juliano, L; Juliano, MA; Monteiro, HP; Oliveira, V; Paschoalin, T; Rodrigues, EG; Travassos, LR | 1 |
| Galmier, MJ; Labarre, P; Madelmont, JC; Papon, J; Rapp, M; Sauzière, J; Vivier, M | 1 |
| Behrens, CH; Behrens, DL; Chen, SF; Fredericks, JR; Kirshenbaum, MR; Papp, LM; Polkus, ST; Sipple, P; Stafford, MM; Sun, JH | 1 |
| Belowski, D; Herman, ZS; Kowalski, J; Madej, A | 1 |
| Glinsky, GV; Glinsky, VV; Kiriakova, G; Metcalf, JB; Mossine, VV; Price, JE | 1 |
| Beltran, PJ; Bucana, CD; Fan, D; Fidler, IJ; Wang, YF; Yoon, SS | 1 |
| Fujimoto, Y; Hashimoto, Y; Kadoya, S; Kagechika, H; Kato, F; Kato, M; Koiso, Y; Komoda, M; Miyata, K; Takayama, H | 1 |
| Abe, F; Black, PL; Pelus, LM; Talmadge, JE | 2 |
| Kurita, Y; Nakao, H; Ogawa, H; Takamori, K; Tsuboi, R | 2 |
| Abe, F; Black, PL; Schneider, M; Talmadge, JE | 1 |
| Abe, F; Alvord, G; Koyama, M; Matsuda, A; Talmadge, JE | 1 |
| Hovingh, P; Linker, A; Piepkorn, M | 1 |
19 other study(ies) available for leucine and B16 Melanoma
| Article | Year |
|---|---|
Amino acids and RagD potentiate mTORC1 activation in CD8
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Enzyme Activation; HEK293 Cells; Homeodomain Proteins; Humans; Leucine; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Mechanistic Target of Rapamycin Complex 1; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Knockout; Monomeric GTP-Binding Proteins; Phenotype; Signal Transduction; Skin Neoplasms; Tumor Escape; Tumor Microenvironment | 2021 |
Validation study of ¹³¹I-RRL: assessment of biodistribution, SPECT imaging and radiation dosimetry in mice.
Topics: Animals; Arginine; Humans; Leucine; Melanoma, Experimental; Mice; Molecular Probes; Neovascularization, Pathologic; Peptides; Radiation Dosage; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2013 |
Branched-chain amino acids complex inhibits melanogenesis in B16F0 melanoma cells.
Topics: 1-Methyl-3-isobutylxanthine; Agaricales; Amino Acids; Animals; Arbutin; Biocatalysis; Biosynthetic Pathways; Biphenyl Compounds; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Free Radical Scavengers; Isoleucine; Leucine; Melanins; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Picrates; Valine | 2012 |
New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Cell Death; Cell Membrane; Fluoresceins; Hemolysis; Humans; Leucine; Lysine; Male; Melanoma, Experimental; Membrane Lipids; Microscopy, Confocal; Mitomycin; Phosphatidylserines; Prostatic Neoplasms; Protein Conformation; Rhodamines; Skin; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Structure-Activity Relationship; Surface Plasmon Resonance; Tumor Cells, Cultured | 2003 |
A derivative of aminopeptidase inhibitor (BE15) has a dual inhibitory effect of invasion and motility on tumor and endothelial cells.
Topics: Aminopeptidases; Animals; Antibiotics, Antineoplastic; Capillaries; Cell Line; Cell Movement; Cell Survival; Endothelial Cells; Extracellular Matrix; Humans; Leucine; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Neoplasms; Protease Inhibitors; Wound Healing | 2006 |
Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growth.
Topics: Angiogenic Proteins; Animals; Antineoplastic Agents; Bradykinin; Cell Extracts; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cloning, Molecular; Coculture Techniques; Collagen; Culture Media, Conditioned; Dipeptides; Dose-Response Relationship, Drug; Drug Combinations; Endothelial Cells; Female; Hydrolysis; Laminin; Leucine; Melanoma, Experimental; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Neurotensin; Nitric Oxide; Nitric Oxide Donors; Oligopeptides; Peptides; Phenanthrolines; Protease Inhibitors; Proteoglycans; S-Nitroso-N-Acetylpenicillamine; Substrate Specificity | 2007 |
Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Iodine Radioisotopes; Leucine; Melanoma, Experimental; Mice; Neoplasm Transplantation; Oligopeptides; Phthalic Acids; Proteasome Inhibitors; Radiopharmaceuticals; Stereoisomerism; Tissue Distribution; Transplantation, Heterologous; Triazenes | 2008 |
(R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Division; Clinical Trials, Phase I as Topic; Colonic Neoplasms; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Isoquinolines; KB Cells; Kinetics; Leucine; Leukemia L1210; Leukemia P388; Mammary Neoplasms, Experimental; Melanoma; Melanoma, Experimental; Mesylates; Mice; Mitoxantrone; Thymidine; Transplantation, Heterologous; Tumor Cells, Cultured; Uridine | 1994 |
Antitumor activity of bestatin and thiorphan in mice.
Topics: Animals; Antineoplastic Agents; Drug Synergism; Female; Killer Cells, Natural; Leucine; Macrophages; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Naloxone; Protease Inhibitors; Thiorphan | 1995 |
Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Topics: Amino Acids; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Drug Screening Assays, Antitumor; Female; Glycoconjugates; Humans; Lectins; Leucine; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Peanut Agglutinin; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1996 |
Intratumoral heterogeneity for and epigenetic modulation of mdr-1 expression in murine melanoma.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Cell Count; Cell Cycle; Cell Division; Drug Resistance, Multiple; Female; Gene Expression; Immunohistochemistry; In Situ Hybridization; Leucine; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Phosphorylation; Phosphotyrosine; Proliferating Cell Nuclear Antigen; Tritium; Tumor Cells, Cultured; Tyrosine | 1997 |
Potent homophthalimide-type inhibitors of B16F10/L5 mouse melanoma cell invasion.
Topics: Aminopeptidases; Animals; Antineoplastic Agents; Enzyme Inhibitors; Humans; Hydroxamic Acids; Isoquinolines; Leucine; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Tumor Cells, Cultured | 1999 |
Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice.
Topics: Animals; Antibiotics, Antineoplastic; Bone Marrow Diseases; Cyclophosphamide; Drug Therapy, Combination; Female; Hematopoiesis; Hematopoietic Stem Cells; Leucine; Melanoma, Experimental; Mice; Mice, Inbred C57BL | 1991 |
Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice.
Topics: Aminopeptidases; Animals; Bone Marrow; Cell Count; Cyclophosphamide; Drug Therapy, Combination; Hematopoietic Stem Cells; Immune Tolerance; Leucine; Lung Neoplasms; Melanoma, Experimental; Mice | 1990 |
Differences in induction of lysosomal protease activity by protease inhibitors in B16 melanoma cell lines.
Topics: Acid Phosphatase; Animals; Cathepsin B; Enzyme Induction; Leucine; Leupeptins; Melanoma, Experimental; Mice; Oligopeptides; Pepstatins; Peptide Hydrolases; Protease Inhibitors; Subcellular Fractions; Tumor Cells, Cultured | 1989 |
Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.
Topics: Adjuvants, Immunologic; Animals; Combined Modality Therapy; Cyclophosphamide; Cytotoxicity, Immunologic; Immunity, Cellular; Killer Cells, Natural; Leucine; Lymphoma; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental | 1989 |
Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Drug Administration Schedule; Injections, Intravenous; Leucine; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL | 1989 |
Induction and inhibition of cathepsin B and hemoglobin-hydrolase activity in murine B16 melanoma by thiol protease inhibitors.
Topics: Animals; Antipain; Cathepsin B; Kinetics; Leucine; Leupeptins; Melanoma, Experimental; Mice; Oligopeptides; Peptide Hydrolases; Protease Inhibitors | 1986 |
Glycosaminoglycans of BALB/c 3T3 and B16.F10 melanoma cells. Metabolic differences.
Topics: Animals; Cells, Cultured; Glycosaminoglycans; Kinetics; Leucine; Melanoma, Experimental; Mice; Sulfates; Sulfur Radioisotopes; Tritium | 1987 |